RT Journal Article
T1 Prevalence of Migraine in General Spanish Population  Factors Related and Use of Health Resources
A1 Salazar, Alejandro
A1 Berrocal, Laura
A1 Failde, Inmaculada
K1 migraine
K1 mental comorbidity
K1 health services
K1 healthcare services
K1 headache
K1 Chronic pain
K1 Epidemiology
K1 Disorders
K1 Anxiety
K1 Spain
K1 Association
K1 Depression
K1 Quality
K1 People
K1 Burden
AB Migraine is a common neurological disorder considered the second most disabling condition worldwide. Its prevalence ranges from 2.6% to 21.7% in population studies. This study aimed to know the prevalence of diagnosed and undiagnosed migraine in the general Spanish adult population, their health care use, and factors related. A descriptive cross-sectional study was undertaken with 23,089 individuals > 15 years from the 2017 Spanish National Health Survey. Three groups were defined: people diagnosed with migraine (DM), people reporting undiagnosed migraine (UM) and people without migraine. Sociodemographic, clinical and use of health resources data were collected. The scales Duke Social Support Index (DSSI) and General Health Questionnaire (GHQ-12) were used. Prevalence of DM and UM were determined with 95% confidence intervals. To determine the factors associated with DM and UM, a multinomial logistic regression model was used. The prevalence of DM was 8.6% (95%CI: 8.2-9), and UM, 0.9% (95%CI: 0.8-1). People with DM more frequently visited healthcare professionals (47.8%), required more supplementary tests (86.8), had a higher percentage of hospitalization (11.3%), and used emergency services (45.1%). Women had nearly three times the risk of DM and UM. Worse mental health was a risk factor for UM (OR = 1.20) and DM (OR = 1.18). The greater the work stress, the greater the risk of DM (OR = 1.12). An adequate monitoring and management of migraine in people with these characteristics could contribute to improving their quality of life and reducing costs in the system.
PB Mdpi
YR 2021
FD 2021-11-01
LK https://hdl.handle.net/10668/25237
UL https://hdl.handle.net/10668/25237
LA en
DS RISalud
RD Apr 12, 2025